LONDON - Aptamer Group plc (AIM: APTA), a developer of Optimer® binders for the life sciences industry, announced on Monday that Tim Sykes, a Non-Executive Director, has purchased 2,667,868 ordinary shares at 0.3369 pence each. This transaction occurred on the London Stock Exchange (LON:LSEG) and increases Sykes's total beneficial interest in the company to 5,171,720 shares, which is approximately 0.26% of Aptamer's issued share capital.
The purchase aligns with the UK Market Abuse Regulation's disclosure requirements for transactions by individuals in managerial positions. The information provided is part of an initial notification regarding the director's dealings with the company's shares.
Aptamer Group has been at the forefront of developing Optimer® binders, which are designed to advance innovation within the life sciences field. The company's shares are publicly traded on the AIM market of the London Stock Exchange.
The disclosure of this share acquisition offers a glimpse into the confidence that the company's leadership has in its future prospects. This transaction is based on a press release statement from Aptamer Group plc and is reported here to provide investors with up-to-date and factual information about the company's directorial dealings.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.